SCHEMBL13779352

SCHEMBL13779352

O=C1C(F)=C(F)C(=O)c2c(F)c(F)c(F)c(F)c21

nearest known ligand 0.32

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 1/20 0.32
GRIN3B O60391 1/20 0.32
GRIN1 Q05586 1/20 0.32
GRIN2A Q12879 1/20 0.32
GRIN2B Q13224 1/20 0.32
GRIN2C Q14957 1/20 0.32
GRIN3A Q8TCU5 1/20 0.32
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA7 P43166 1/20 0.32
CA13 Q8N1Q1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8369799 0.85 CA1 (0.35) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL5872482 0.81 GRIN2D (0.33) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL465016 0.71
SCHEMBL9619705 0.69 KDM4E (0.34)
SCHEMBL7515268 0.69 GRIN2D (0.30) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL6650819 0.67 MEN1 (0.55)
SCHEMBL321124 0.66
SCHEMBL14157195 0.66
SCHEMBL14157108 0.66
SCHEMBL7174935 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767308-B2 Method of stabilizing perfluorodioxolane compound, perfluorodioxolane compound-containing composition and method of producing perfluorodioxolane compound polymer TOSOH CORPORATION (JP) 2023-09-26 US disclosed
US-11767308-B2 Method of stabilizing perfluorodioxolane compound, perfluorodioxolane compound-containing composition and method of producing perfluorodioxolane compound polymer TOSOH CORPORATION (JP) 2023-09-26 US disclosed
US-11767308-B2 Method of stabilizing perfluorodioxolane compound, perfluorodioxolane compound-containing composition and method of producing perfluorodioxolane compound polymer TOSOH CORPORATION (JP) 2023-09-26 US disclosed
US-20230068345-A1 METHOD OF STABILIZING PERFLUORODIOXOLANE COMPOUND, PERFLUORODIOXOLANE COMPOUND-CONTAINING COMPOSITION AND METHOD OF PRODUCING PERFLUORODIOXOLANE COMPOUND POLYMER TOSOH CORPORATION (JP) 2023-03-02 US disclosed
CN-114901651-A Method for stabilizing perfluorodioxolane compound, composition containing perfluorodioxolane compound, and method for producing perfluorodioxolane compound polymer 东曹株式会社 2022-08-12 CN disclosed
WO-2021132640-A1 METHOD FOR STABILIZING PERFLUORODIOXOLANE COMPOUND, COMPOSITION INCLUDING PERFLUORODIOXOLANE COMPOUND, AND METHOD FOR MANUFACTURING PERFLUORODIOXOLANE COMPOUND POLYMER 東ソ-株式会社 2021-07-01 WO disclosed
CN-110446715-A Organic compound, light-emitting component, light emitting device, electronic equipment, display device and lighting device SEMICONDUCTOR ENERGY LAB 2019-11-12 CN disclosed
CN-110383522-A Light-emitting element material, light-emitting component, light emitting device, electronic equipment, lighting device and organometallic complex 株式会社半导体能源研究所 2019-10-25 CN disclosed
CN-110117267-A Light-emitting component, light emitting device, electronic equipment and lighting device 株式会社半导体能源研究所 2019-08-13 CN disclosed
CN-108604641-A Light-emitting element, light-emitting device, electronic device, and lighting device 株式会社半导体能源研究所 2018-09-28 CN disclosed
US-8884093-B2 Method of treating effluents containing halogenated compounds CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) 2014-11-11 US disclosed
US-20130041200-A1 METHOD OF TREATING EFFLUENTS CONTAINING HALOGENATED COMPOUNDS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) 2013-02-14 US disclosed
US-20090176773-A1 Non-Peptidic Inhibitors of AKAP/PKA Interaction FORSCHUNGSVERBUND BERLIN E.V. (DE) 2009-07-09 US disclosed
US-20090176773-A1 Non-Peptidic Inhibitors of AKAP/PKA Interaction FORSCHUNGSVERBUND BERLIN E.V. (DE) 2009-07-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11767308-B2 Method of stabilizing perfluorodioxolane compound, perfluorodioxolane compound-containing composition and method of producing perfluorodioxolane compound polymer PFAS, PFN1, PFKFB1 GRIN2D 3064/4885GRIN3B 4316/4885GRIN1 2455/4885
US-20230068345-A1 METHOD OF STABILIZING PERFLUORODIOXOLANE COMPOUND, PERFLUORODIOXOLANE COMPOUND-CONTAINING COMPOSITION AND METHOD OF PRODUCING PERFLUORODIOXOLANE COMPOUND POLYMER PFAS, PFN1, PFKFB1 GRIN2D 3064/4885GRIN3B 4316/4885GRIN1 2455/4885
US-20090176773-A1 Non-Peptidic Inhibitors of AKAP/PKA Interaction PRKCH, AIP, PRKCE GRIN2D 3947/4885GRIN3B 2587/4885GRIN1 2682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.